icon-folder.gif   Conference Reports for NATAP  
 
  ICAAC 2015 55th Interscience Conference
on Antimicrobial Agents and Chemotherapy
September 5-9, 2015, San Diego, CA
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetics, Safety and Tolerability of EDP-239, a Novel Hepatitis C (HCV) NS5A inhibitor, in Patients with HCV Infection
 
 
  Reported by Jules Levin
ICAAC 2015 Sept 17-21 San Diego, CA
 
Lijuan Jiang1, Xuemin Jiang2, Kiran Dole2, Eric Lawitz3, Fred Poordad3, Stefan Zeuzem4, Kimberly Caliri1, Kenneth Tack1, Richard Colvin2, Yat Sun Or1 1Enanta Pharmaceuticals Inc., Watertown MA; 2Novartis Institutes for Biomedical Research, Cambridge MA; 3The Texas Liver Institute, San Antonio TX; 4Goethe University Hospital, Frankfurt, Germany

ICAAC1.gif

ICAAC2.gif

ICAAC3.gif

ICAAC4.gif

ICAAC5.gif

ICAAC6.gif

ICAAC7.gif

ICAAC8.gif

ICAAC9.gif